Topics

Moderna, raising cash, quickly advances coronavirus candidate

06:45 EST 11 Feb 2020 | BioPharmaDive

A initial batch of the biotech's mRNA vaccine could soon be sent to the NIH for use in a Phase 1 study, which would mark a rapid scale-up to clinical testing. 

Original Article: Moderna, raising cash, quickly advances coronavirus candidate

NEXT ARTICLE

More From BioPortfolio on "Moderna, raising cash, quickly advances coronavirus candidate"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...